Skip to main content
OpenTrials

Clinical trial condition

Retinitis Pigmentosa

Explore clinical trials studying Retinitis Pigmentosa. Study availability and eligibility vary by location and protocol.

159 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Retinitis Pigmentosa trial results

Active, Not Recruiting

FIGHT-RP 1 Extension Study

NCT03999021

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Wilmer Eye Institute at Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

CNS10-NPC for the Treatment of RP

NCT04284293

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
View Trial Details
Active, Not Recruiting

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

NCT05203939

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Enhanced S-Cone Syndrome, Eye Diseases, +9 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Ocugen Site 5 - University of California, San Diego (UCSD) - Shiley Eye Institute La Jolla, California, United States
  • Ocugen Site 3 - Bascom Palmer Eye Institute Miami, Florida, United States
  • Ocugen Site 6 - Emory University Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

NCT06162585

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +13 more
Locations
  • Nanoscope Clinical Site Beverly Hills, California, United States
  • Nanoscope Clinical Site Pensacola, Florida, United States
  • Nanoscope Clinical Site Fargo, North Dakota, United States
  • Nanoscope Clinical Site Houston, Texas, United States
View Trial Details

Related conditions